Smith & Nephew
SNN | NYSE
$30.97
-$0.31 (-0.99%)
At close: Nov 16, 2026, 4:00 PM ET
$30.97
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:55 PM ET
Smith & Nephew Company Profile
Company profile explainedCompany Profile
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Key Executives
| Name | Position |
|---|---|
| Deepak S. Nath | Chief Executive Officer & Director |
| John Terence Rogers | Chief Financial Officer |
| Ajay Dhankhar | Chief Corporate Development & Strategy Officer |
| Alison Parkes | Chief Compliance Officer & Compliance APAC |
| Charles Reynolds | Head of Corporate Communication |
| Elga Lohler | Chief Human Resources Officer |
| Emily Heaven | Head of Investor Relations |
| Helen Barraclough | Group General Counsel & Company Secretary |
| Paul Connolly | President of Global Operations |
| Pierre Palassian | Interim CFO, Senior VP of Finance & Group Controller |
| Steve Kane | Head of Human Resources for the US, Global Marketing and Global R&D |
| Vasant Padmanabhan | President Research & Development, ENT and Emerging Markets |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 22, 2026 | 6-K | Filing |
| Oct 09, 2026 | S-8 | Filing |
| Oct 08, 2026 | 6-K | Filing |
| Oct 05, 2026 | 25-NSE | Filing |
| Oct 01, 2026 | 6-K | Filing |
| Oct 01, 2026 | 6-K | Filing |
| Sep 18, 2026 | 6-K | Filing |
| Sep 18, 2026 | 6-K | Filing |
| Sep 17, 2026 | CERT | Filing |
| Sep 16, 2026 | 6-K | Filing |
Smith & Nephew
| Country | United Kingdom |
| IPO Date | Nov 16, 1999 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 18,362 |
| CEO | Deepak S. Nath |
Contact Details
Building 5 Croxley Park Hatters Lane Watford,
HRT WD18 8YE United Kingdom
Stock Details
| Ticker Symbol | SNN |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000845982 |
| CUSIP Number | 83175M205 |
| ISIN Number | US83175M2052 |
| SIC Code | 3842 |
Recent News
- 8 days ago / marketbeat.comSmith & Nephew SNATS Q3 Earnings Call Highlights
- 11 days ago / seekingalpha.comSmith & Nephew: Sluggish Growth And Shifting Outlook Now Make It Less Attractive (Rating Downgrade)
- 13 days ago / seekingalpha.comSmith & Nephew plc (SNN) Q3 2026 Sales/Trading Call Transcript
- 1 month ago / zacks.comSmith+Nephew Launches CARTIHEAL Implant Across Key European Markets
- 1 month ago / globenewswire.comSmith+Nephew's revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal
- 1 month ago / globenewswire.comSmith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l'innovativo impianto per la riparazione della cartilagine, che sarà presentato all'ICRS Summit in Portogallo.
- 1 month ago / globenewswire.comSmith+Nephew lanza en Europa el innovador implante de reparación de cartílago CARTIHEAL™ AGILI-C™, que será protagonista en el Congreso ICRS de Portugal
- 2 months ago / zacks.comSmith+Nephew Launches EVOS PELVIC System to Advance Trauma Care
- 2 months ago / globenewswire.comMULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
- 2 months ago / globenewswire.comSmith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
Add to Watchlist
Select watchlists to add or remove SNN